Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission

被引:58
作者
Li, FW
Templeton, TJ
Popov, V
Comer, JE
Tsuboi, T
Torii, M
Vinetz, JM
机构
[1] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA
[2] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[3] Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA
[4] Ehime Univ, Sch Med, Dept Mol Parasitol, Shigenobu, Ehime 7910295, Japan
关键词
D O I
10.1074/jbc.M401385200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mosquito midgut ookinete stage of the malaria parasite, Plasmodium, possesses microneme secretory organelles that mediate locomotion and midgut wall egress to establish sporogonic stages and subsequent transmission. The purpose of this study was 2-fold: 1) to determine whether there exists a single micronemal population with respect to soluble and membrane-associated secreted proteins; and 2) to evaluate the ookinete micronemal proteins chitinase (PgCHT1), circumsporozoite and TRAP-related protein (CTRP), and von Willebrand factor A domain-related protein ( WARP) as immunological targets eliciting sera-blocking malaria parasite infectivity to mosquitoes. Indirect immunofluorescence localization studies in Plasmodium gallinaceum using specific antisera showed that all three proteins are distributed intracellularly with a similar granular cytoplasmic appearance and with focal concentration of PgCHT1 and PgCTRP, but not PgWARP, at the ookinete apical end. Immunogold double-labeling electron microscopy, using antisera against the membrane-associated protein CTRP and the soluble WARP, showed that these two proteins co-localized to the same micronemal population. Within the microneme CTRP was associated peripherally at the microneme membrane, whereas PgCHT1 and WARP were diffuse within the micronemal lumen. Sera produced against Plasmodium falciparum WARP significantly reduced the infectivity of P. gallinaceum to Aedes aegypti and P. falciparum to Anopheles mosquitoes. Antisera against PgCTRP and PgCHT1 also significantly reduced the infectivity of P. gallinaceum for A. aegypti. These results support the concept that ookinete micronemal proteins may constitute a general class of malaria transmission-blocking vaccine candidates.
引用
收藏
页码:26635 / 26644
页数:10
相关论文
共 32 条
[1]   Analysis of the Plasmodium and Anopheles transcriptional repertoire during ookinete development and midgut invasion [J].
Abraham, EG ;
Islam, S ;
Srinivasan, P ;
Ghosh, AK ;
Valenzuela, JG ;
Ribeiro, JMC ;
Kafatos, FC ;
Dimopoulos, G ;
Jacobs-Lorena, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) :5573-5580
[2]   PERITROPHIC MEMBRANES AND PROTEASE ACTIVITY IN THE MIDGUT OF THE MALARIA MOSQUITO, ANOPHELES-STEPHENSI (LISTON) (INSECTA, DIPTERA) UNDER NORMAL AND EXPERIMENTAL CONDITIONS [J].
BERNER, R ;
RUDIN, W ;
HECKER, H .
JOURNAL OF ULTRASTRUCTURE RESEARCH, 1983, 83 (02) :195-204
[3]   Transmission blocking malaria vaccines [J].
Carter, R .
VACCINE, 2001, 19 (17-19) :2309-2314
[5]   CTRP is essential for mosquito infection by malaria ookinetes [J].
Dessens, JT ;
Beetsma, AL ;
Dimopoulos, G ;
Wengelnik, K ;
Crisanti, A ;
Kafatos, FC ;
Sinden, RE .
EMBO JOURNAL, 1999, 18 (22) :6221-6227
[6]   Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice [J].
Gozar, MMG ;
Price, VL ;
Kaslow, DC .
INFECTION AND IMMUNITY, 1998, 66 (01) :59-64
[7]   Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes [J].
Hisaeda, H ;
Stowers, AW ;
Tsuboi, T ;
Collins, WE ;
Sattabongkot, JS ;
Suwanabun, N ;
Torii, M ;
Kaslow, DC .
INFECTION AND IMMUNITY, 2000, 68 (12) :6618-6623
[9]   CHARACTERIZATION OF ANTIGENS ON MOSQUITO MIDGUT STAGES OF PLASMODIUM-GALLINACEUM .2. COMPARISON OF SURFACE-ANTIGENS OF MALE AND FEMALE GAMETES AND ZYGOTES [J].
KAUSHAL, DC ;
CARTER, R .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1984, 11 (APR) :145-156
[10]  
KAUSHAL DC, 1983, J IMMUNOL, V131, P2557